Seguir
Morten Hansen
Morten Hansen
National Center for Cancer Immune Therapy at Copenhagen University Hospital
Dirección de correo verificada de regionh.dk
Título
Citado por
Citado por
Año
The effect of short-chain fatty acids on human monocyte-derived dendritic cells
C Nastasi, M Candela, CM Bonefeld, C Geisler, M Hansen, T Krejsgaard, ...
Scientific reports 5 (1), 16148, 2015
3642015
Predictors of responses to immune checkpoint blockade in advanced melanoma
N Jacquelot, MP Roberti, DP Enot, S Rusakiewicz, N Ternès, S Jegou, ...
Nature communications 8 (1), 592, 2017
1892017
Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells
C Nastasi, S Fredholm, A Willerslev-Olsen, M Hansen, CM Bonefeld, ...
Scientific reports 7 (1), 14516, 2017
882017
The role of dendritic cells in cancer
M Hansen, MH Andersen
Seminars in immunopathology 39, 307-316, 2017
852017
Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma
R Andersen, M Donia, MCW Westergaard, M Pedersen, M Hansen, ...
Human vaccines & immunotherapeutics 11 (12), 2790-2795, 2015
792015
CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment
E Martinenaite, S Munir Ahmad, M Hansen, Ö Met, MW Westergaard, ...
Oncoimmunology 5 (11), e1238541, 2016
742016
Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study
P Kongsted, TH Borch, E Ellebaek, TZ Iversen, R Andersen, Ö Met, ...
Cytotherapy 19 (4), 500-513, 2017
702017
In-chip fabrication of free-form 3D constructs for directed cell migration analysis
MH Olsen, GM Hjortø, M Hansen, Ö Met, IM Svane, NB Larsen
Lab on a Chip 13 (24), 4800-4809, 2013
692013
Differential CCR7 targeting in dendritic cells by three naturally occurring CC-chemokines
GM Hjortø, O Larsen, A Steen, V Daugvilaite, C Berg, S Fares, M Hansen, ...
Frontiers in Immunology 7, 218657, 2016
672016
Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients
C Jensen, DH Madsen, M Hansen, H Schmidt, IM Svane, MA Karsdal, ...
Journal for Immunotherapy of Cancer 6, 1-10, 2018
642018
Expansion of circulating CD56bright natural killer cells in patients with JAK2‐positive chronic myeloproliferative neoplasms during treatment with interferon‐α
CH Riley, M Hansen, MK Brimnes, H Hans C., OW Bjerrum, P Straten, ...
European Journal of Haematology, 2014
552014
Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion
M Donia, M Hansen, SL Sendrup, TZ Iversen, E Ellebæk, MH Andersen, ...
Journal of Investigative Dermatology, 2012
542012
Injection molded chips with integrated conducting polymer electrodes for electroporation of cells
KØ Andresen, M Hansen, M Matschuk, ST Jepsen, HS Sørensen, P Utko, ...
Journal of Micromechanics and Microengineering 20, 055010, 2010
512010
Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy
M Hansen, GM Hjortø, M Donia, Ö Met, NB Larsen, MH Andersen, ...
Vaccine 31 (4), 639-646, 2013
442013
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine
S Munir Ahmad, E Martinenaite, M Hansen, N Junker, TH Borch, Ö Met, ...
Oncoimmunology 5 (8), e1202391, 2016
412016
Cellular Based Cancer Vaccines: Type 1 Polarization of Dendritic Cells
M Hansen, O Met, IM Svane, MH Andersen
Current Medicinal Chemistry 19 (25), 4239-4246, 2012
412012
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma
TH Borch, L Engell-Noerregaard, T Zeeberg Iversen, E Ellebaek, Ö Met, ...
Oncoimmunology 5 (9), e1207842, 2016
372016
Granzyme B degraded type IV collagen products in serum identify melanoma patients responding to immune checkpoint blockade
C Jensen, D Sinkeviciute, DH Madsen, P Önnerfjord, M Hansen, ...
Cancers 12 (10), 2786, 2020
342020
Interferon‐α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK 2V617F‐positive essential thrombocythemia …
CH Riley, MK Brimnes, M Hansen, MK Jensen, HC Hasselbalch, L Kjaer, ...
European Journal of Haematology 97 (1), 83-92, 2016
342016
Therapeutic cancer vaccination with a peptide derived from the calreticulin exon 9 mutations induces strong cellular immune responses in patients with CALR-mutant chronic …
J Handlos Grauslund, MO Holmström, NG Jørgensen, U Klausen, ...
Frontiers in oncology 11, 637420, 2021
332021
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20